Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2021-08-06 Major Shareholding Noti…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
110年年報及股東會資料 — 2021_3164_20210528F17.pdf
Major Shareholding Notification Classification · 95% confidence The document contains a table listing the top ten shareholders of a company, their shareholdings, and the relationships among them. It is dated March 30, 110 (likely referring to a calendar year in Taiwan's Minguo calendar, corresponding to 2021). The content focuses on shareholding percentages and relationships between shareholders, which aligns with notifications about major shareholdings or changes in significant ownership levels. The document is short (1151 characters) and does not contain financial statements or management commentary. Therefore, it is best classified as a Major Shareholding Notification (MRQ).
2021-08-06 Chinese
110年年報及股東會資料 — 2020_3164_20210528F04.pdf
Annual Report Classification · 100% confidence The document is titled as the '109年度年報' which translates to the 'Annual Report for the year 109' (Taiwanese calendar year, corresponding to 2020). It includes detailed sections such as shareholder reports, company governance, financial data, capital and shares, operational overview, and financial summary. The presence of detailed financial and operational data, governance reports, and auditor information strongly indicates this is a full annual report. The document length is substantial (15,000 characters), and it is not a brief announcement or a certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2020
2021-08-06 Chinese
110年年報及股東會資料 — 2021_3164_20210528F02.pdf
Annual Report Classification · 98% confidence The document is a detailed shareholder meeting manual for GenMont Biotech Inc., including the agenda, reports, and attachments for the Annual General Meeting (AGM) held in May of the 111th year of the Republic of China calendar (equivalent to 2022). It contains the 109th fiscal year business report, audit committee review report, buyback of treasury shares report, auditor's report, and the 109th fiscal year financial statements. The presence of the full business report, audited financial statements, and detailed financial data indicates this is the actual Annual Report document rather than just an announcement or summary. The document is comprehensive and exceeds 15,000 characters, containing substantive financial data and analysis. Therefore, it fits the definition of an Annual Report (10-K). FY 2020
2021-08-06 Chinese
110年年報及股東會資料 — 2021_3164_20210528F13.pdf
AGM Information Classification · 95% confidence The document is titled as materials related to a shareholders' meeting (股東常會) for GenMont Biotech Inc. It includes detailed agenda items such as business reports, financial statements for the fiscal year 109 (which corresponds to 2020 in the Gregorian calendar), dividend distribution proposals, and capital surplus cash distribution proposals. The document contains detailed explanations and references to attachments with financial reports and audit committee reviews. The presence of meeting agenda, proposals for approval, and detailed explanations indicates this is material prepared for the Annual General Meeting (AGM). The document length is under 5,000 characters and is not merely an announcement of a report but contains substantive meeting materials. Therefore, it fits the category of AGM Information (AGM-R).
2021-08-06 Chinese
110年年報及股東會資料 — 2021_3164_20210528F01.pdf
AGM Information Classification · 100% confidence The document is a detailed notice for the Annual General Meeting (AGM) of 景岳生物科技股份有限公司, including the date, location, agenda items such as approval of financial statements, dividend distribution, and other shareholder meeting procedures. It contains instructions for shareholders on proxy voting, attendance, and voting rights, as well as COVID-19 related precautions for attending the meeting. The document is not a financial report itself but a formal notification and invitation to shareholders to attend and vote at the AGM. It does not contain financial statements or management discussion but focuses on the meeting logistics and agenda. Therefore, it fits the category of AGM Information (AGM-R).
2021-08-06 Chinese
110年07月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, chairman, general manager, and other executives. It shows the number of shares held, changes in holdings, and related information. The content is focused on insider share transactions and holdings, not on financial results, management changes, or other report types. There is no indication of a full annual or quarterly report, earnings release, or other financial disclosures. The document is a report of personal share transactions by company directors and executives, fitting the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider holdings, confirming it is not a mere announcement or certification.
2021-08-05 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.